Qinghai Spring Medicinal Resources Technology Co., Ltd. Stock
Equities
600381
CNE0000017W0
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.17 CNY | +0.48% | +5.57% | -46.05% |
Sales 2021 | 128M 17.63M | Sales 2022 | 160M 22.11M | Capitalization | 7.23B 997M |
---|---|---|---|---|---|
Net income 2021 | -249M -34.37M | Net income 2022 | -288M -39.75M | EV / Sales 2021 | 37.2 x |
Net cash position 2021 | 198M 27.39M | Net cash position 2022 | 164M 22.7M | EV / Sales 2022 | 44.1 x |
P/E ratio 2021 |
-20.1
x | P/E ratio 2022 |
-25.1
x | Employees | 175 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 55.91% |
1 day | +0.48% | ||
1 week | +5.57% | ||
Current month | -21.47% | ||
1 month | -24.18% | ||
3 months | -37.01% | ||
6 months | -40.09% | ||
Current year | -46.05% |
Managers | Title | Age | Since |
---|---|---|---|
Xue Feng Zhang
CEO | Chief Executive Officer | 55 | 15-10-29 |
Lin Wang
DFI | Director of Finance/CFO | 55 | 18-05-17 |
Tie Peng Yao
BRD | Director/Board Member | 71 | 15-05-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xue Min Gao
BRD | Director/Board Member | 86 | 20-06-03 |
Rong Xiao
BRD | Director/Board Member | 54 | - |
Xue Feng Zhang
CEO | Chief Executive Officer | 55 | 15-10-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.33% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 4.17 | +0.48% | 9,989,500 |
24-04-22 | 4.15 | -2.35% | 13,223,610 |
24-04-19 | 4.25 | +1.67% | 19,215,100 |
24-04-18 | 4.18 | +1.70% | 16,677,790 |
24-04-17 | 4.11 | +4.05% | 19,675,060 |
End-of-day quote Shanghai S.E., April 22, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.05% | 338M | |
+37.15% | 6.01B | |
-16.04% | 4.47B | |
-11.16% | 3.11B | |
-1.40% | 3.01B | |
+0.12% | 2.6B | |
+38.69% | 1.85B | |
+1.11% | 1.66B | |
-10.34% | 1.63B | |
-12.97% | 1.53B |
- Stock Market
- Equities
- 600381 Stock